California Public Employees Retirement System Provention Bio, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.71 - $11.04 $649,528 - $1.07 Million	-96,800 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$10.12 - $19.45 $89,956 - $172,891	-8,889 Reduced 8.41%	96,800 $1.02 Million
Q4 2020 Feb 02, 2021	SELL	$11.79 - $18.94 $23,580 - $37,880	-2,000 Reduced 1.86%	105,689 $1.79 Million
Q3 2020 Nov 05, 2020	BUY	$10.34 - $15.2 $143,591 - $211,082	13,887 Added 14.8%	107,689 $1.38 Million
Q2 2020 Aug 12, 2020	BUY	$7.81 - $17.0 $193,125 - $420,376	24,728 Added 35.8%	93,802 $1.32 Million
Q1 2020 May 12, 2020	BUY	$5.42 - $17.75 $127,370 - $417,125	23,500 Added 51.56%	69,074 $635,000
Q4 2019 Jan 27, 2020	BUY	$5.84 - $14.9 $266,152 - $679,052	45,574 New	45,574 $679,000

Others Institutions Holding PRVB

# of Institutions

Shares Held

170K

Call Options Held

Put Options Held

Odey Asset Management Group LTD London, X0

170K
Shares

$0
1.36% of portfolio

View Full List

About Provention Bio, Inc.

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

More about PRVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account